Journal
JOURNAL OF NUCLEAR MEDICINE
Volume 53, Issue 8, Pages 1244-1252Publisher
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.112.109306
Keywords
MRI; PET; PET/MRI; oncology
Ask authors/readers for more resources
With integrated whole-body PET/MRI, a novel metabolic-anatomic imaging technique recently has been introduced into clinical practice. This review addresses PET/MRI of bone tumors, soft-tissue sarcoma, melanoma, and lymphoma. If PET/MRI literature is not yet available for some types of tumors, potential indications are based on available PET/CT and MRI data. PET/MRI seems to be of benefit in T-staging of primary bone tumors and soft-tissue sarcomas. With regard to N-staging, PET/MRI can be considered similarly accurate to PET/CT when applied as a whole-body staging approach. M-staging will benefit from MA) accuracy in the brain, the liver, and bone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available